OTC Markets OTCPK - Delayed Quote USD

DNAPrint Genomics, Inc. (DNAG)

0.0000
+0.0000
+(500.00%)
At close: May 22 at 10:52:58 AM EDT
Loading Chart for DNAG
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0000
  • Volume 3,665
  • Avg. Volume 58
  • Market Cap (intraday) 232,059
  • Beta (5Y Monthly) 111.25
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.

24

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DNAG

View More

Performance Overview: DNAG

Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DNAG
70.00%
S&P 500 (^GSPC)
0.51%

1-Year Return

DNAG
85.00%
S&P 500 (^GSPC)
12.92%

3-Year Return

DNAG
94.00%
S&P 500 (^GSPC)
42.17%

5-Year Return

DNAG
94.00%
S&P 500 (^GSPC)
94.19%

Compare To: DNAG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DNAG

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -235.65%

  • Return on Assets (ttm)

    -105.00%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.93M

  • Net Income Avi to Common (ttm)

    -4.55M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    134.35k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.42M

Research Analysis: DNAG

View More

Company Insights: DNAG

Research Reports: DNAG

View More

People Also Watch